3/7/2007 12:33:51 PM
AUSTIN, Texas--(BUSINESS WIRE)--The University of Texas at Austin (UT Austin) announced today that it has licensed a drug delivery technology developed by the UT Austin team of Nicholas Peppas, Sc.D., Mark Byrne, Ph.D., and Zach Hilt, Ph.D., to Mimetic Solutions, LLC, an Emergent Technologies Fund IV portfolio company. Dr. Peppas will serve as Co-Chief Scientist of Mimetic Solutions, along with Dr. Hilt, now on faculty at the University of Kentucky. Mimetic Solutions will be managed by Emergent Technologies, Inc. (ETI), with Dr. Brian Windsor serving as Managing Director.
comments powered by